GenSight Biologics S.A. (GSGTF)

GenSight Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	21	34	28	166	290	372
Market Cap Growth	-45.02%	20.63%	-82.90%	-42.89%	-21.99%	308.86%
Enterprise Value	44	51	51	157	250	371
Last Close Price	0.19	0.24	0.47	3.15	6.75	8.59
PS Ratio	19.33	12.59	8.66	31.90	33.13	40.91
PB Ratio	-0.57	-1.23	-0.84	-10.16	15.97	25.91
P/TBV Ratio	-	-	-	-	16.09	26.20
EV/Sales Ratio	38.97	18.59	15.53	30.25	28.53	40.80
Debt / Equity Ratio	-0.59	-0.71	-0.77	-1.17	1.10	1.63
Asset Turnover	0.09	0.26	0.17	0.12	0.15	0.19
Quick Ratio	0.06	0.20	0.18	0.96	2.18	2.41
Current Ratio	0.11	0.24	0.26	1.57	2.40	2.56
Return on Equity (ROE)	-	-	-	-7781.69%	-206.34%	-305.52%
Return on Assets (ROA)	-85.07%	-99.39%	-105.83%	-42.13%	-33.80%	-39.03%
Return on Capital Employed (ROCE)	83.20%	133.30%	183.80%	-246.30%	-81.80%	-82.50%
Earnings Yield	-82.76%	-42.36%	-102.16%	-17.80%	-11.21%	-11.18%
FCF Yield	-	-39.14%	-96.14%	-21.91%	-6.72%	-4.95%
Buyback Yield / Dilution	-77.81%	-98.18%	-4.29%	-2.61%	-28.54%	-23.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.